NCT02928250View on ClinicalTrials.gov

Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

May 31, 2016

Conditions
Type 1 DiabetesOxidative StressCarnosineDiabetic Nephropathy
Interventions
DIETARY_SUPPLEMENT

Carnosine

Patients in intervention group received carnosine capsules orally daily

DIETARY_SUPPLEMENT

Placebo

Patients in placebo group received placebo that were similar in appearance to carnosine capsules and the administered dose was as the same schedule as carnosine.

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02928250 - Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes | Biotech Hunter | Biotech Hunter